Short and long term impacts

The acute situation regarding COVID-19 and its economic consequences for the industry does not negate the need for a long-term approach in working to improve conditions for Swedish life science.

SwedenBIO recently submitted its response to Vinnova’s proposed technology park function for ESS and MaxIV, which has been developed in the working group for R&D and provides both praise and criticism and concretization of the proposals submitted. Increased availability of research infrastructure is an important part of strengthening Sweden’s attractiveness for research investments and supporting the research product companies, but transparency needs to be increased regarding how projects gain access. The work to implement the life science strategy was on the agenda when the collaboration group for the government’s life science office met digitally on May 5.